hepatitis B

Bluejay raises $41M to bring hepatitis B drugs to clinical testing
BioPharma Dive
Fri, 08/19/22 - 10:39 am
Bluejay Therapeutics
hepatitis B
funding
Hepatitis B: can GSK’s bepirovirsen deliver functional cure?
Clinical Trials Arena
Fri, 07/29/22 - 10:10 am
GSK
bepirovirsen
hepatitis B
antisense
Assembly Bio scraps hepatitis B drug, cuts staff after clinical setback
BioPharma Dive
Thu, 07/21/22 - 09:54 pm
Assembly Biosciences
hepatitis B
layoffs
vebicorvir
GSK hepatitis B hope bepirovirsen heads for phase 3 test
Pharmaforum
Mon, 06/27/22 - 10:18 am
GSK
hepatitis B
clinical trials
antisense
bepirovirsen
Antios rocked as hepatitis B safety signal sparks clinical hold, termination of collaboration
Fierce Biotech
Wed, 05/25/22 - 10:34 am
Antios
hepatitis B
Assembly Biosciences
FDA
J&J ends hepatitis B and HPV portions of Bavarian Nordic collab
Endpoints
Mon, 05/9/22 - 10:33 am
JNJ
Janssen
Bavarian Nordic
vaccines
hepatitis B
HPV
Xbiome acquires live biotherapeutic product program targeting ulcerative colitis
Biopharma Reporter
Thu, 04/28/22 - 10:39 pm
Xbiome
microbiome
hepatitis B
artificial intelligence
ulcerative colitis
Finch clips wings of hepatitis B program, hitting pause on clinical plan to focus on C. diff and autism
Fierce Biotech
Fri, 04/1/22 - 10:38 am
Finch Therapeutics
hepatitis B
microbiome
clinical trials
autism
C. difficile
Aligos Takes Another Hit with Halt of Hep B Therapy
BioSpace
Wed, 03/23/22 - 10:31 am
Aligos Therapeutics
hepatitis B
ALG-020572
adverse events
clinical trials
Gilead to limit 340B discounts for hepatitis C drugs
Beckers Hospital Review
Wed, 03/16/22 - 11:28 pm
Gilead Sciences
340B
hepatitis B
Aligos says stop right now to lead hep B med after fruitless phase 1 data
Fierce Biotech
Thu, 01/6/22 - 11:56 pm
Aligos Therapeutics
hepatitis B
clinical trials
VBI Vaccines Gets FDA Approval for First Three-Antigen Hepatitis B Shot
Xtalks
Tue, 12/7/21 - 10:46 am
VBI Vaccines
FDA
hepatitis B
vaccines
PreHevbrio
Antios, months after series B, raises a further $75M to fuel pursuit of hepatitis B cure
Fierce Biotech
Wed, 11/3/21 - 10:46 am
Antios
hepatitis B
ATI-2173
funding
Race for hepatitis B drug intensifies as Antios raises $96m for phase 2 trial
Pharmaforum
Tue, 04/13/21 - 10:18 am
Antios
funding
hepatitis B
ATI-2173
Drug Farm bags $56M to take novel hepatitis B drug into humans
Fierce Biotech
Tue, 02/9/21 - 11:28 am
Drug Farm
hepatitis B
funding
drug development
Gilead & Vir Announce Collaboration To Find Cure For Hepatitis B Virus
NASDAQ
Tue, 01/12/21 - 11:01 am
Gilead Sciences
Vir Biotechnology
hepatitis B
clinical trials
Assembly Bio's hepatitis B program flops as a potential cure in PhII, sending shares spiraling
Endpoints
Sat, 11/7/20 - 11:06 pm
Assembly Biosciences
hepatitis B
clinical trials
vebicorvir
New data from J&J, Arrowhead mark latest step in RNAi's hepatitis B race
BioPharma Dive
Sat, 08/29/20 - 11:42 pm
Arrowhead Pharmaceuticals
JNJ
clinical trials
RNAi
hepatitis B
J&J's RNAi suppresses hepatitis B for 48 weeks after last dose
Fierce Biotech
Fri, 08/28/20 - 10:47 am
JNJ
RNAi
JNJ-3989
hepatitis B
Ionis deal delivers for GSK as HBV drug hits the mark in phase 2
Pharmaforum
Fri, 08/28/20 - 10:36 am
GSK
antisense
hepatitis B
clinical trials
GSK3228836
Ionis Pharmaceuticals

Pages